APA (7th ed.) Citation

SS, S., TS, W., FY, C., YS, Y., TT, C., MW, H., . . . JW, L. (2026). Clinical implications of cefoperazone-sulbactam MIC values in Pseudomonas aeruginosa bloodstream infections: A multicentre study. JAC-antimicrobial resistance, 8(3), dlag073. https://doi.org/10.1093/jacamr/dlag073

Chicago Style (17th ed.) Citation

SS, Shie, et al. "Clinical Implications of Cefoperazone-sulbactam MIC Values in Pseudomonas Aeruginosa Bloodstream Infections: A Multicentre Study." JAC-antimicrobial Resistance 8, no. 3 (2026): dlag073. https://doi.org/10.1093/jacamr/dlag073.

MLA (9th ed.) Citation

SS, Shie, et al. "Clinical Implications of Cefoperazone-sulbactam MIC Values in Pseudomonas Aeruginosa Bloodstream Infections: A Multicentre Study." JAC-antimicrobial Resistance, vol. 8, no. 3, 2026, p. dlag073, https://doi.org/10.1093/jacamr/dlag073.